Clinical trial Recruiting at 1 site Interventional Ages 19 and up

Comparing two methods for using saphenous vein in heart bypass surgery

Official title: Comparison Between the Saphenous Vein as Y-composite Graft Based on the Left Internal Thoracic Artery Versus Aortocoronary Conduit for Coronary Artery Bypass Grafting: A Prospective Randomized Controlled Trial

Run by Seoul National University Hospital · NCT05704296 · Data updated 2026-11-12

This study is testing two different ways to use a vein from the leg in heart bypass surgery to see which method works better for patients.

Quick facts

Study typeInterventional
Ages19 Years and up
SexAll
Enrollment290 (estimated)
SponsorSeoul National University Hospital
Academic / other
Locations1 site (Seoul)
StatusRecruiting
StartedApril 18, 2023
Main results expectedMarch 31, 2027
Study endsJanuary 31, 2028
Registry record updatedSeptember 17, 2026
Trial IDNCT05704296 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 19 years old who are scheduled for CABG involving the left internal thoracic artery and saphenous vein graft.

Probably not a fit

Patients with severe comorbidities, those requiring other surgical procedures, or those with unsuitable grafts will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the effectiveness of two different grafting techniques for coronary artery bypass grafting (CABG) using the saphenous vein. Patients will be randomized to receive either a Y-composite graft with the left internal thoracic artery or an aortocoronary conduit. The study aims to assess the morphologic changes of the saphenous vein graft and its patency at one year through intravascular ultrasound and angiography. The trial will involve routine sternotomy and follow-up evaluations to determine clinical outcomes.

Why it matters

Potential benefit: If successful, this study could improve the long-term success rates of CABG procedures by identifying the optimal use of saphenous vein grafts.

How similar studies have gone: Previous studies have shown promising results with the 'No touch saphenous vein' technique, but this specific comparison of graft configurations is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* A patient who is going to receive coronary artery bypass grafting
* Older than 19 years
* Coronary artery bypass grafting is going to be performed with left internal thoracic artery and saphenous vein graft

Exclusion Criteria:

* Other concomitant procedures (e.g. valve or aorta surgery) is planned
* Patients with severe comorbidities which limit the life expectancy of them below 1 year (e.g. terminal cancer)
* Patients whose left internal thoracic artery or saphenous vein is not available due to the low quality, severe injury, or absence of the graft
* Patients whose ascending aorta is not suitable to aortocoronary anastomosis (e.g. ascending aorta aneurysm, porcelain aorta)
* Emergency operation
* Patients who have connective tissue disease
* Reoperative coronary artery bypass grafting

Where it's running

  • Seoul National University Hospital
    Seoul, South Korea
    Recruiting

Study contacts

  • Principal investigator: Ho Young Hwang, MD, PhD — Seoul National University Hospital
  • Study coordinator: Ho Young Hwang, MD, PhD
  • Email: scalpel@snu.ac.kr
  • Phone: 00-82-10-4004-3673

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.